Financial Health Check: Examining CVS Health Corp (CVS)’s Key Ratios

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

CVS Health Corp (NYSE: CVS) closed the day trading at $57.52 down -1.08% from the previous closing price of $58.15. In other words, the price has decreased by -$1.08 from its previous closing price. On the day, 6.88 million shares were traded. CVS stock price reached its highest trading level at $58.22 during the session, while it also had its lowest trading level at $57.2292.

Ratios:

For a better understanding of CVS, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.50 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.87. For the most recent quarter (mrq), Quick Ratio is recorded 0.61 and its Current Ratio is at 0.81. In the meantime, Its Debt-to-Equity ratio is 1.11 whereas as Long-Term Debt/Eq ratio is at 0.99.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on May 30, 2024, initiated with a Neutral rating and assigned the stock a target price of $61.

On May 07, 2024, TD Cowen Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $99 to $59.

UBS Downgraded its Buy to Neutral on May 02, 2024, whereas the target price for the stock was revised from $85 to $60.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 02 ’24 when Mahoney Michael F bought 9,181 shares for $54.49 per share. The transaction valued at 500,294 led to the insider holds 9,356 shares of the business.

LUDWIG EDWARD J bought 1,000 shares of CVS for $53,879 on May 02 ’24. The Director now owns 21,630 shares after completing the transaction at $53.88 per share. On Feb 16 ’24, another insider, Shah Prem S, who serves as the EVP and Pres-Pharm, Consumer W of the company, sold 29,473 shares for $76.95 each. As a result, the insider received 2,267,947 and left with 39,765 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CVS now has a Market Capitalization of 72999780352 and an Enterprise Value of 141094060032. As of this moment, CVS’s Price-to-Earnings (P/E) ratio for their current fiscal year is 10.11, and their Forward P/E ratio for the next fiscal year is 7.31. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.20 while its Price-to-Book (P/B) ratio in mrq is 0.97. Its current Enterprise Value per Revenue stands at 0.392 whereas that against EBITDA is 8.337.

Stock Price History:

The Beta on a monthly basis for CVS is 0.51, which has changed by -0.17344445 over the last 52 weeks, in comparison to a change of 0.23886502 over the same period for the S&P500. Over the past 52 weeks, CVS has reached a high of $83.25, while it has fallen to a 52-week low of $52.77. The 50-Day Moving Average of the stock is -3.79%, while the 200-Day Moving Average is calculated to be -17.79%.

Shares Statistics:

Over the past 3-months, CVS traded about 12.87M shares per day on average, while over the past 10 days, CVS traded about 10807730 shares per day. A total of 1.29B shares are outstanding, with a floating share count of 1.25B. Insiders hold about 0.18% of the company’s shares, while institutions hold 81.64% stake in the company. Shares short for CVS as of 1718323200 were 20644808 with a Short Ratio of 1.60, compared to 1715731200 on 11374710. Therefore, it implies a Short% of Shares Outstanding of 20644808 and a Short% of Float of 1.6500000000000001.

Dividends & Splits

CVS’s forward annual dividend rate is 2.54, up from 2.48 a year ago. Against a Trailing Annual Dividend Yield of 0.042648323The stock’s 5-year Average Dividend Yield is 2.88. The current Payout Ratio is 38.34% for CVS, which recently paid a dividend on 2024-04-19 with an ex-dividend date of 1713484800. Stock splits for the company last occurred on 2005-06-07 when the company split stock in a 2:1 ratio.

Most Popular